Diphenhydramine Completed Phase 4 Trials for Urinary Incontinence (UI) / Clostridium Botulinum Toxin Adverse Reaction / Parkinson's Disease (PD) / Neurogenic Bladder Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01421719Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease